• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 29 of 100
COVID Delta Delta plus variants
Newsletters
The delta between the Delta variants
By Sy MukherjeeJune 24, 2021
Janet Woodcock, acting commissioner of the U.S. Food and Drug Administration (FDA), listens during a Senate Appropriations Subcommittee hearing in Washington, D.C., U.S., on Thursday, June 10, 2021. The hearing is titled "Fiscal Year 2022 Budget Request for the FDA." Photographer: Al Drago/Bloomberg via Getty Images
Health
Pressure mounts on Biden to nominate permanent FDA head as dissatisfaction with agency grows
By Sy MukherjeeJune 22, 2021
A woman in an Allcyte lab coat looking at images of cancer cells on a screen.
Tech
British A.I. drug discovery startup Exscientia buys Austrian cancer cell screening company
By Jeremy KahnJune 15, 2021
The exterior of the headquarters of biotechnology company Biogen in Cambridge, MA is pictured on March 21, 2019.
Health
Biogen won its controversial Alzheimer’s drug approval. Which drugmakers will see the next big win?
By Sy MukherjeeJune 9, 2021
Cassava Sciences—a drugmaker with no products on the market—is currently 2021’s best biotech performer
Health
Cassava Sciences—a drugmaker with no products on the market—is currently 2021’s best biotech performer
By Cristin Flanagan and BloombergJune 8, 2021
Amazon begins offering six-month prescriptions for as low as $6
Health
Amazon begins offering six-month prescriptions for as low as $6
By Chris MorrisJune 8, 2021
The exterior of the headquarters of biotechnology company Biogen in Cambridge, MA is pictured on March 21, 2019.
Health
FDA approves Biogen’s controversial Alzheimer’s drug in historic decision
By Sy MukherjeeJune 7, 2021
FDA Biogen Alzheimer's Janet Woodcock
Health
President Biden still hasn’t appointed a permanent FDA commissioner. That has big implications for upcoming drug approvals
By Sy MukherjeeMay 25, 2021
Colorado lawmakers wage multi-front assault on high drug costs
Health
Colorado lawmakers wage multi-front assault on high drug costs
By Markian Hawryluk and Kaiser Health NewsMay 24, 2021
AbbVie drug price hikes
Health
Will AbbVie, maker of the world’s best-selling drug, finally face the music over its price hikes?
By Sy MukherjeeMay 19, 2021
Making cancer treatments affordable today won’t hurt tomorrow’s innovation
Commentary
Making cancer treatments affordable today won’t hurt tomorrow’s innovation
By Rena Conti, Richard Frank and Leslie DachMay 12, 2021
Independent pharmacies are fighting to stay in business through the pandemic
Health
Independent pharmacies are fighting to stay in business through the pandemic
By Markian Hawryluk and Kaiser Health NewsApril 29, 2021
GoodRx helps people afford drugs. But is it improving health care or profiting off a broken system?
Features
GoodRx helps people afford drugs. But is it improving health care or profiting off a broken system?
By Erika FryApril 29, 2021
Brainstorm Health 2021-Moderna-Stephane Bancel
Conferences
Moderna is working toward a single shot for both COVID and flu protection
By Sy MukherjeeApril 27, 2021
One billion COVID vaccines
Newsletters
Would a free water bottle convince you to get a COVID vaccine?
By Sy MukherjeeApril 26, 2021
1...
  • 27
  • 28
  • 29
  • 30
  • 31
...100
Most Popular
Arts & Entertainment
Ed Sheeran asked Patriots owner Robert Kraft for $2 million aid donation after Macklemore was dropped from his tour for pro-Palestine commentsplaceholder alt text
By Marco Quiroz-GutierrezSeptember 18, 2026
C-Suite
Meet Warren Buffett's son Howard, a former sheriff, war photographer, and now, Berkshire's new chairmanplaceholder alt text
By Catherina GioinoSeptember 18, 2026
Success
Anthropic billionaire cofounder Jack Clark studied literature, not code—and says liberal arts degrees will win in the AI ageplaceholder alt text
By Marco Quiroz-GutierrezSeptember 19, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.